Business and Industrial News Items from June 18, 2010

GlaxoSmithKline (NYSE: GSK) and Merck & Co., Inc. (NYSE: MRK) announced today the U.S. Food and Drug Administration (FDA) has approved STAXYN™ (vardenafil HCI), an orally disintegrating tablet indicated for the treatment of erectile dysfunction (ED).... ...